BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 29030773)

  • 1. Outcome prediction with the revised American joint committee on cancer staging system and American thyroid association guidelines for thyroid cancer.
    Suh S; Kim YH; Goh TS; Lee J; Jeong DC; Oh SO; Hong JC; Kim SJ; Kim IJ; Pak K
    Endocrine; 2017 Dec; 58(3):495-502. PubMed ID: 29030773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projecting Survival in Papillary Thyroid Cancer: A Comparison of the Seventh and Eighth Editions of the American Joint Commission on Cancer/Union for International Cancer Control Staging Systems in Two Contemporary National Patient Cohorts.
    Pontius LN; Oyekunle TO; Thomas SM; Stang MT; Scheri RP; Roman SA; Sosa JA
    Thyroid; 2017 Nov; 27(11):1408-1416. PubMed ID: 28891405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
    Yang F; Zhong Q; Huang Z; Lian M; Fang J
    Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting recurrence of papillary thyroid cancer using the eighth edition of the AJCC/UICC staging system.
    Chereau N; Oyekunle TO; Zambeli-Ljepović A; Kazaure HS; Roman SA; Menegaux F; Sosa JA
    Br J Surg; 2019 Jun; 106(7):889-897. PubMed ID: 31012500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Recurrence in Differentiated Thyroid Cancer: A Population-Based Comparison of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems.
    Gan T; Huang B; Chen Q; Sinner HF; Lee CY; Sloan DA; Randle RW
    Ann Surg Oncol; 2019 Sep; 26(9):2703-2710. PubMed ID: 30830539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 7th and 8th editions of the UICC/AJCC TNM staging for non-small cell lung cancer in a non-metastatic North American cohort undergoing primary radiation treatment.
    Koul R; Rathod S; Dubey A; Bashir B; Chowdhury A
    Lung Cancer; 2018 Sep; 123():116-120. PubMed ID: 30089581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: Results from a non-endemic cohort with 10-year follow-up.
    Wu LR; Zhang XM; Xie XD; Lu Y; Wu JF; He X
    Oral Oncol; 2019 Nov; 98():141-146. PubMed ID: 31586896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of long-term prognosis for differentiated thyroid cancer according to the 7th and 8th editions of the AJCC/UICC TNM staging system.
    Kim K; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
    Ther Adv Endocrinol Metab; 2020; 11():2042018820921019. PubMed ID: 32489582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An International Multi-Institutional Validation of Age 55 Years as a Cutoff for Risk Stratification in the AJCC/UICC Staging System for Well-Differentiated Thyroid Cancer.
    Nixon IJ; Wang LY; Migliacci JC; Eskander A; Campbell MJ; Aniss A; Morris L; Vaisman F; Corbo R; Momesso D; Vaisman M; Carvalho A; Learoyd D; Leslie WD; Nason RW; Kuk D; Wreesmann V; Morris L; Palmer FL; Ganly I; Patel SG; Singh B; Tuttle RM; Shaha AR; Gönen M; Pathak KA; Shen WT; Sywak M; Kowalski L; Freeman J; Perrier N; Shah JP
    Thyroid; 2016 Mar; 26(3):373-80. PubMed ID: 26914539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of the Seventh and Eighth Editions of the AJCC Staging Systems to Predict Recurrence in Papillary Thyroid Microcarcinoma.
    Chen Z; Ruan J; Yao Y; Wen L; Mao Z; Chen S; Zhu H; Zhao Y; Li Z; Fahey TJ; Teng L; Wang W
    Ann Surg Oncol; 2021 Oct; 28(11):6564-6571. PubMed ID: 33521903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.
    Zhi J; Wu Y; Hu L; Zhao J; Liu H; Ruan X; Hou X; Zhang J; Zheng X; Gao M
    Int J Clin Oncol; 2020 Jan; 25(1):59-66. PubMed ID: 31414270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of staging systems for differentiated thyroid carcinoma in an endemic goiter region with iodine substitution.
    Passler C; Prager G; Scheuba C; Kaserer K; Zettinig G; Niederle B
    Ann Surg; 2003 Feb; 237(2):227-34. PubMed ID: 12560781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poorly differentiated thyroid cancer in the context of the revised 2015 American Thyroid Association Guidelines and the Updated American Joint Committee on Cancer/Tumor-Node-Metastasis Staging System (eighth edition).
    Walczyk A; Kopczyński J; Gąsior-Perczak D; Pałyga I; Kowalik A; Chrapek M; Hejnold M; Góźdź S; Kowalska A
    Clin Endocrinol (Oxf); 2019 Aug; 91(2):331-339. PubMed ID: 30525210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions.
    Tam S; Boonsripitayanon M; Amit M; Fellman BM; Li Y; Busaidy NL; Cabanillas ME; Dadu R; Sherman S; Waguespack SG; Williams MD; Goepfert RP; Gross ND; Perrier ND; Sturgis EM; Zafereo ME
    Thyroid; 2018 Oct; 28(10):1301-1310. PubMed ID: 30141373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer.
    Ghaznavi SA; Ganly I; Shaha AR; English C; Wills J; Tuttle RM
    Thyroid; 2018 Oct; 28(10):1293-1300. PubMed ID: 29897011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Analysis of The American Joint Committee on Cancer 8th Edition T Staging System for Papillary Thyroid Carcinoma.
    Tran B; Roshan D; Abraham E; Wang L; Garibotto N; Wykes J; Campbell P; Ebrahimi A
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2199-2206. PubMed ID: 29672723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Value of Lymph Node Ratio Integration with the 8
    Lee J; Lee SG; Kim K; Yim SH; Ryu H; Lee CR; Kang SW; Jeong JJ; Nam KH; Chung WY; Jo YS
    Sci Rep; 2019 Sep; 9(1):13361. PubMed ID: 31527831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.